Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Devonian Health Group Inc DVHGF


Primary Symbol: V.GSD

Healthcare
Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. It is also involved in the development of value-added products for dermo-cosmetics and the distribution... see more

Recent & Breaking News (TSXV:GSD)

Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder

Business Wire January 22, 2021

Devonian Health Group Announces Closing of a Private Placement and the Grant of Stock Options

Business Wire December 30, 2020

Devonian Announces the Issuance of Units in Settlement of Interests Owed to Debenture Holders

Business Wire October 9, 2020

Devonian Announces Correction to Press Release Issued July 28, 2020

Business Wire July 30, 2020

Devonian Announces the Issuance of Units in Settlement of Interests Owed to a Debenture Holder and Stock Option Grants

Business Wire July 28, 2020

Devonian Health Group Announces Notice of Allowance for a US Patent Application Covering Use of Thykamine(TM) for the Treatment of Ulcerative Colitis

Business Wire June 15, 2020

Devonian Health Group Announces Completion of Enrollment in Its Phase 2 Clinical Trial of Thykamine(TM) for the Treatment of Mild-to-Moderate Atopic Dermatitis in Adult Population

Business Wire June 10, 2020

Devonian Health Group Announces Change to its Board of Directors

Business Wire June 5, 2020

Devonian Health Group Announces an Exclusive Strategic Alliance with CannTx Life Sciences for the development of Cannabinoid-based Pharmaceutical Drugs.

Business Wire June 4, 2020

Devonian Health Group Announces the nomination of Dr André P. Boulet to the American Botanical Drug Association.

Business Wire May 21, 2020

Devonian Health Group Announces the Closing of $1,805,000 Non-Brokered Financing

Business Wire May 4, 2020

Devonian Health Group Announces an Increase to Its Non-Brokered Financing to $2,000,000

Business Wire April 24, 2020

Devonian Health Group Announces the Issuance of Securities in Interest Settlement Due to Debenture Holders, a $330,000 Non-Brokered Financing and the Grant of Options

Business Wire April 22, 2020

Devonian Health Group Announces R-Spinasome® Anti-aging Technology Global Sales and Marketing Partnership.

Business Wire February 11, 2020

Devonian Issues Settlements of Interest Due to a Debenture Holder and Announces the Results of the Annual General Meeting of Shareholders

Business Wire January 29, 2020

Devonian Health Group Announces Presentation to the World Conference on Ageing and Gerontology and a Correction on Expiry Date of Warrants

Business Wire January 23, 2020

Devonian Health Group Announces Cannabis Cutting-Edge Extraction Equipment in Its Montmagny Facility

Business Wire January 15, 2020

Devonian Health Group Obtains Cannabis Research License from Health Canada.

Business Wire October 3, 2019

Devonian Health Group Announces the Formation of a Clinical Dermatology Advisory Board With Mandate to Assist in the Development of Cannabinoids-Based Pharmaceutical Products.

Business Wire September 4, 2019

Devonian Health Group Announces the Publication of Positive Results of the Purgenesis® Anti-Aging Care Clinical Study in the Journal of Cosmetic Dermatology.

Business Wire August 29, 2019